A Metalloproteinase Secreted by Streptococcus pneumoniae Removes Membrane Mucin MUC16 from the Epithelial Glycocalyx Barrier
Open Access
- 7 March 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (3) , e32418
Abstract
The majority of bacterial infections occur across wet-surfaced mucosal epithelia, including those that cover the eye, respiratory tract, gastrointestinal tract and genitourinary tract. The apical surface of all these mucosal epithelia is covered by a heavily glycosylated glycocalyx, a major component of which are membrane-associated mucins (MAMs). MAMs form a barrier that serves as one of the first lines of defense against invading bacteria. While opportunistic bacteria rely on pre-existing defects or wounds to gain entry to epithelia, non opportunistic bacteria, especially the epidemic disease-causing ones, gain access to epithelial cells without evidence of predisposing injury. The molecular mechanisms employed by these non opportunistic pathogens to breach the MAM barrier remain unknown. To test the hypothesis that disease-causing non opportunistic bacteria gain access to the epithelium by removal of MAMs, corneal, conjunctival, and tracheobronchial epithelial cells, cultured to differentiate to express the MAMs, MUCs 1, 4, and 16, were exposed to a non encapsulated, non typeable strain of Streptococcus pneumoniae (SP168), which causes epidemic conjunctivitis. The ability of strain SP168 to induce MAM ectodomain release from epithelia was compared to that of other strains of S. pneumoniae, as well as the opportunistic pathogen Staphylococcus aureus. The experiments reported herein demonstrate that the epidemic disease-causing S. pneumoniae species secretes a metalloproteinase, ZmpC, which selectively induces ectodomain shedding of the MAM MUC16. Furthermore, ZmpC-induced removal of MUC16 from the epithelium leads to loss of the glycocalyx barrier function and enhanced internalization of the bacterium. These data suggest that removal of MAMs by bacterial enzymes may be an important virulence mechanism employed by disease-causing non opportunistic bacteria to gain access to epithelial cells to cause infection.Keywords
This publication has 47 references indexed in Scilit:
- Membrane-tethered mucins have multiple functions on the ocular surfaceExperimental Eye Research, 2010
- Mucin-interacting proteins: from function to therapeuticsTrends in Biochemical Sciences, 2010
- Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial BarrierJournal of Biological Chemistry, 2009
- CA125/MUC16 Is Dispensable for Mouse Development and ReproductionPLOS ONE, 2009
- Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?American Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Isolation of Streptococcus pneumoniae Biofilm Mutants and Their Characterization during Nasopharyngeal ColonizationInfection and Immunity, 2008
- Focus on Molecules: Human mucin MUC16Experimental Eye Research, 2008
- Release of Membrane-Associated Mucins from Ocular Surface EpitheliaInvestigative Ophthalmology & Visual Science, 2008
- MUC1 cell surface mucin is a critical element of the mucosal barrier to infectionJournal of Clinical Investigation, 2007
- Assay of mucins in human tear fluidExperimental Eye Research, 2007